News

The CHF16m ($17m) facility will annually produce about 7,000 tonnes of products including Resource, Isosource and Sustagen, which are designed for managing diabetes, renal disorders and malnutrition. Nestle

bluebird bio chief medical officer David Davidson said bluebird bio has made advances in lentiviral vector design, transduction efficiency and in manufacturing process, enabling the production of gene-modified

VC-01 when implanted under diabetes patient’s skin is expected to produce insulin and other factors to control diabetes. ViaCyte’s stem cell-based therapy for diabetes has also received CIRM

The solution, Medcurial, is designed to help Filipino doctors and clinics to access their appointments schedule, view patient records as well as billing records anywhere. Exist Software Labs

Teva Pharmaceutical Industries Global R&D president and chief scientific officer Michael Hayden said Teva has brought Synribo to the market for patients who need additional treatment options when

New plasmid stability system is designed to achieve plasmid stability throughout the fermentation process by eliminating an essential gene present in the company’s E.coli strains. The essential gene

With the approval, the only once-daily, steroid-containing topical treatment is now indicated for both scalp and body plaque psoriasis for up to eight weeks. Taclonex contains a vitamin

The company began the shipment of the product after winning the final FDA approval. Actos is a prescription medication indicated for type 2 diabetes used along with diet

The firm’s GAAP net income for the third quarter declined to $1.79bn, down from $2.02bn for the same quarter in 2011. Merck’s pharmaceutical sales in the third quarter